Insider Buying Sparks Interest: Recent posts on X have highlighted significant insider buying at Sensus Healthcare, with the CEO and other executives acquiring substantial shares. This activity, reported as recent transactions, has caught the attention of investors monitoring the stock. Many see this as a potential signal of confidence in the company’s future.
Board Changes and Strategic Moves: Discussions on X also focus on the company’s recent board appointment and expanded roles for key executives. Some users have noted concerns over reimbursement cuts for skin substitute treatments, suggesting potential headwinds. These mixed views keep the conversation lively and dynamic.
Note: This discussion summary was generated from an AI condensation of post data.
Sensus Healthcare Insider Trading Activity
Sensus Healthcare insiders have traded $SRTS stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SRTS stock by insiders over the last 6 months:
- JOSEPH C SARDANO (CHIEF EXECUTIVE OFFICER) purchased 25,000 shares for an estimated $100,750
- MICHAEL SARDANO (PRESIDENT AND GENERAL COUNSEL) has made 3 purchases buying 3,000 shares for an estimated $11,430 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Sensus Healthcare Hedge Fund Activity
We have seen 13 institutional investors add shares of Sensus Healthcare stock to their portfolio, and 34 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 668,880 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,100,283
- PERRITT CAPITAL MANAGEMENT INC removed 469,692 shares (-78.9%) from their portfolio in Q3 2025, for an estimated $1,474,832
- ACADIAN ASSET MANAGEMENT LLC removed 148,282 shares (-39.3%) from their portfolio in Q3 2025, for an estimated $465,605
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 128,224 shares (+39.5%) to their portfolio in Q3 2025, for an estimated $402,623
- PACIFIC RIDGE CAPITAL PARTNERS, LLC added 118,628 shares (+26.1%) to their portfolio in Q3 2025, for an estimated $372,491
- MEROS INVESTMENT MANAGEMENT, LP added 74,749 shares (+75.3%) to their portfolio in Q3 2025, for an estimated $234,711
- GSA CAPITAL PARTNERS LLP removed 71,696 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $225,125
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Sensus Healthcare Analyst Ratings
Wall Street analysts have issued reports on $SRTS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 08/12/2025
- Lake Street issued a "Buy" rating on 08/08/2025
To track analyst ratings and price targets for Sensus Healthcare, check out Quiver Quantitative's $SRTS forecast page.
Sensus Healthcare Price Targets
Multiple analysts have issued price targets for $SRTS recently. We have seen 2 analysts offer price targets for $SRTS in the last 6 months, with a median target of $7.0.
Here are some recent targets:
- Yi Chen from HC Wainwright & Co. set a target price of $8.0 on 08/12/2025
- Ben Haynor from Lake Street set a target price of $6.0 on 08/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
